Today: 1 July 2026
Browse Category

NASDAQ:ASTI 27 June 2025

Beaming the Watts Down: NASA × Ascent Solar’s Thin-Film Array Sets the Stage for Space-to-Earth Power Transmission

Beaming the Watts Down: NASA × Ascent Solar’s Thin-Film Array Sets the Stage for Space-to-Earth Power Transmission

Space-based solar power is the ambitious concept of harvesting solar energy in space and beaming it down to Earth. The idea dates back to 1968, when engineer Peter Glaser first proposed placing giant satellites in orbit to collect sunlight and transmit power wirelessly to Earth space.com. In theory, SBSP could tap a virtually unlimited 24/7 supply of solar energy in orbit, free from weather or nightfall. Experts note that orbital solar panels could generate 8 times more power than the same area on Earth’s surface pv-magazine-usa.com. Unlike ground solar or wind farms that stop producing at night or in bad weather, space solar stations could deliver continuous clean energy day and night, potentially displacing fossil fuels and stabilizing grids space.com. Interest in SBSP has surged in recent years thanks to technological advances and the urgency of climate change. Advocates argue that modern robotics, more efficient wireless power transmission, and cheaper heavy-lift rockets like SpaceX’s Starship could finally make SBSP feasible space.com. For example, Starship’s ability to loft large payloads might enable assembly of huge solar arrays in orbit at far lower cost than before. A constellation of satellites in geosynchronous orbit could continuously beam gigawatts of power via microwaves to

Stock Market Today

  • Morgan Stanley Lifts UnitedHealth (UNH) Target to $468 Before Q2 Report
    July 1, 2026, 10:26 AM EDT. Morgan Stanley bumped its price target on UnitedHealth (UNH) to $468 from $453 with Q2 results due July 16, implying about 13% upside. Analyst Erin Wright cited "incrementally reassuring" utilization data and a $1.5 billion AI investment as positives. Bernstein SocGen stuck with an Outperform and a $492 target, calling for Q2 adjusted EPS of $5.22, above consensus. Shares are up 24% for the year, trading close to a 52-week high. The bullish case centers on Medicare Advantage margins and leaving unprofitable contracts. On the other side, TD Cowen cut its target to $197, pointing to growth and regulatory pressures but kept a Buy rating. UnitedHealth's full-year adjusted EPS guidance remains above $18.25, supporting the upbeat view into earnings.
Go toTop